All.Can Greece organized an informational event entitled “Mapping the Efficiency of Cancer Care in Greece: Pilot Implementation of the All.Can Action Guide” on 12 November in Athens, where the results of the Greek pilot implementation of the All.Can Action Guide for Efficient Cancer Care were presented.
The implementation, conducted in collaboration with the University of Piraeus and the University of West Attica under the supervision of Professors Athanasios Vozikis and Kostas Athanasakis, involved eight leading oncology hospitals and several key stakeholders from the healthcare and oncology sectors.
The project was carried out in three main phases:
a) March–July 2025: Evaluation of the efficiency of the Greek healthcare system and its readiness to integrate standardized measurement indicators.
b) September–October 2025: Analysis of quantitative and qualitative data, identification of key findings, and development of recommendations.
c) November 2025: Presentation of results and completion of the final report.
Some of the key findings of the Greek Pilot Study comprise:
- Government commitment and technological infrastructure (cancer registries, digital systems, e-health) have been steadily improving during the last years.
- Progress has been made in the collection and use of patient-reported outcome and experience measures (PROMs/PREMs), as well as in the operation of multidisciplinary teams (MDTs).
- On the other hand, significant gaps remain in oncology services, including the absence of a national cancer strategy, insufficient quality indicators, lack of coordinated monitoring and feedback mechanisms, limited data interoperability, and staffing weaknesses (nurses, patient navigators).
Based on the analysis of the results, All.Can Greece highlights the need for:
- Development of a National Cancer Plan with clear goals, indicators, and monitoring mechanisms.
Integration and interoperability of databases, enabling linkage of clinical and socio-economic data with care outcomes. - Establishment of structured feedback mechanisms between primary and hospital care.
Strengthening the healthcare workforce through needs assessment, improved working conditions, and formalization of new roles. - Enhanced patient involvement through incentives for PROMs/PREMs collection and systematic participation in decision-making processes.
- Introduction of transparency indicators to be publicly and regularly reported, strengthening accountability and public trust.
The pilot implementation of the All.Can Action Guide marks a significant step toward an oncology care system that makes effective use of available resources, responds to the real needs of patients and transforms data and knowledge into action—ultimately improving care for every cancer patient in Greece.
Many representatives from regional health authorities, oncology units, and medical and oncology organizations attended the event, contributing valuable observations and comments on the findings and the significance of the initiative.
Giorgos Kapetanakis, President of the Hellenic Cancer Federation and member of both the All.Can Greece and All.Can International boards, highlighted the recent progress of the Greek healthcare system toward faster, higher-quality, and more patient-centered cancer care.
Eduardo Pisani, CEO of All.Can International emphasized the importance of digital health integration, the value generated by a strong measurement culture, and the need for a tailored strategic framework as key prerequisites for shaping an efficient and effective National Cancer Plan. “What can be measured can be improved,” he noted, encouraging the publication of the Greek findings in a scientific journal.
The findings and recommendations of the pilot will be included in a study to be published in the coming weeks.
The event was made possible thanks to the unconditional support of the All.Can Greece funding partners: AstraZeneca, BMS, Daiichi Sankyo, Genekor, Johnson & Johnson, MSD, Pfizer, Roche.
Click here to read a brief summary of the All.Can Pilot Implementation in Greece.